Evidence map›Paper›PMID 34827341›Full record

ArticleAntibiotics (Basel, Switzerland)2021

First Global Report of Plasmid-Mediated

Josman Dantas Palmeira, Marisa Haenni, Jean-Yves Madec, Helena Maria Neto Ferreira

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Genomic epidemiology and resistome dynamics ofFrontiers in microbiology · 2025
    Article
  4. Article
  5. The Global Rise of ESBL-ProducingAnimals : an open access journal from MDPI · 2024
    Review
  6. Antimicrobial Resistance and Clonal Lineages ofAntibiotics (Basel, Switzerland) · 2023
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Josman Dantas PalmeiraMicrobiology, Biological Sciences Department, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-3729-9942
Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, Anses Laboratoire de Lyon, Université de Lyon, 69007 Lyon, France.ORCID 0000-0003-1333-5603
Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes, Anses Laboratoire de Lyon, Université de Lyon, 69007 Lyon, France.
Helena Maria Neto FerreiraMicrobiology, Biological Sciences Department, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Universidade do Porto · PTUniversité Claude Bernard Lyon 1 · FR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 9152-13-0French Agency for Food, Environmental and Occupational Health & Safety ANSES LyonFundação para a Ciência e Tecnologia Applied Molecular Biosciences Unit-UCIBIO, which is financed by national funds from FCT (UIDP/04378/2020 and UIDB/04378/2020)
6 · The paper itself

Abstract

Resistances to extended-spectrum cephalosporins (ESC) and colistin are One Health issues since genes encoding these resistances can be transmitted between all sectors of the One Health concept, i.e., human, animal, and the environment. Among food-producing animals, sheep farming has long been overlooked. To fill in this knowledge gap, we looked for ESC- and colistin resistance in 21 faecal samples collected from sheep in one farm in the south of Portugal. ESC-resistant isolates were selected on MacConkey agar plates supplemented with cefotaxime. Susceptibility testing was performed by the disk-diffusion method according to CLSI, while colistin MIC was determined by broth microdilution. ESC- and colistin-resistance genes were identified by PCR, and the clonality of all isolates was assessed by

Indexed as

E. coliextended-spectrum beta-lactamasemcr-1Portugalsheep

Identifiers

PMID34827341
PMCPMC8615169
OpenAlexW3213619870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.